Literature DB >> 30147136

Intravenous Push Administration of Antibiotics: Literature and Considerations.

Samantha Spencer1, Heather Ipema1, Patricia Hartke1, Courtney Krueger1, Ryan Rodriguez1, Alan E Gross1, Michael Gabay1.   

Abstract

Intravenous (IV) push administration can provide clinical and practical advantages over longer IV infusions in multiple clinical scenarios, including in the emergency department, in fluid-restricted patients, and when supplies of diluents are limited. In these settings, conversion to IV push administration may provide a solution. This review compiles available data on IV push administration of antibiotics in adults, including preparation, stability, and administration instructions. Prescribing information, multiple tertiary drug resources, and primary literature were consulted to compile relevant data. Several antibiotics are Food and Drug Administration-approved for IV push administration, including many beta-lactams. In addition, cefepime, ceftriaxone, ertapenem, gentamicin, and tobramycin have primary literature data to support IV push administration. While amikacin, ciprofloxacin, imipenem/cilastatin, and metronidazole have limited primary literature data on IV push administration, available data do not support that route. In addition, a discussion on practical considerations, such as IV push best practices and pharmacodynamic considerations, is provided.

Entities:  

Keywords:  anti-infectives; drug stability; intravenous therapy

Year:  2018        PMID: 30147136      PMCID: PMC6102793          DOI: 10.1177/0018578718760257

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  76 in total

1.  Tobramycin and gentamicin can safely be given by slow push.

Authors:  Mark R Loewenthal; Pauline M Dobson
Journal:  J Antimicrob Chemother       Date:  2010-06-19       Impact factor: 5.790

2.  Implementation of the i.v. push method of antibiotic administration using the FOCUS/PDCA approach.

Authors:  B Miano; W Wood
Journal:  Home Healthc Nurse       Date:  1998-12

3.  Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.

Authors:  Sutep Jaruratanasirikul; Somchai Sriwiriyajan; Jarurat Punyo
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

5.  Letter: Serum-gentamicin levels after intravenous bolus injection.

Authors: 
Journal:  Lancet       Date:  1974-08-31       Impact factor: 79.321

6.  Disposition studies with amikacin after rapid intravenous and intramuscular administration to human volunteers.

Authors:  R A Yates; M Mitchard
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

7.  Intravenous Push Cephalosporin Antibiotics in the Emergency Department: A Practice Improvement Project.

Authors:  Julie M McLaughlin; Robin A Scott; Stephanie L Koenig; Scott W Mueller
Journal:  Adv Emerg Nurs J       Date:  2017 Oct/Dec

8.  Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.

Authors:  J T Stewart; F W Warren; S M Johnson; J L Fox; J Mullaney
Journal:  Am J Hosp Pharm       Date:  1992-11

9.  Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers.

Authors:  Dora E Wiskirchen; Seth T Housman; Richard Quintiliani; David P Nicolau; Joseph L Kuti
Journal:  Pharmacotherapy       Date:  2013-02-11       Impact factor: 4.705

10.  Absence of tobramycin pharmacokinetic and creatinine clearance variation during the menstrual cycle: implied absence of variation in glomerular filtration rate.

Authors:  A N Nafziger; M S Schwartzman; J S Bertino
Journal:  J Clin Pharmacol       Date:  1989-08       Impact factor: 3.126

View more
  3 in total

1.  Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.

Authors:  Todd A Riccobene; Timothy J Carrothers; William Knebel; Susan Raber; Phylinda L S Chan
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-19

Review 2.  Surgical Antibiotic Prophylaxis in an Era of Antibiotic Resistance: Common Resistant Bacteria and Wider Considerations for Practice.

Authors:  Bradley D Menz; Esmita Charani; David L Gordon; Andrew J M Leather; S Ramani Moonesinghe; Cameron J Phillips
Journal:  Infect Drug Resist       Date:  2021-12-07       Impact factor: 4.003

3.  Implementation of IV Push Antibiotics for Outpatients During a National Fluid Shortage Following Hurricane Maria.

Authors:  Kruti J Yagnik; L Steven Brown; Hala A Saad; Kristin Alvarez; Norman Mang; Cylaina E Bird; Fred Cerise; Kavita P Bhavan
Journal:  Open Forum Infect Dis       Date:  2022-03-21       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.